))
Transforming Healthcare: The Power of Next-Generation Diagnostics in Personalized Medicine
Manage episode 378651679 series 3396813
内容由Perry Dimas提供。所有播客内容（包括剧集、图形和播客描述）均由 Perry Dimas 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
The goal of personalized medicine is to pinpoint the most effective treatments and reduce the morbidity and toxicity associated with unnecessary therapies. One of the major challenges in the field is securing reimbursement for personalized medicine services. While Medicare often leads the way in adopting new approaches, other payers vary in their criteria, making it a complex landscape to navigate.
Our guest today is Matt Mega, the Senior Vice President of Market Access at Natera. He emphasizes the importance of identifying patients who will truly benefit from specific treatments, sparing others from unnecessary risks and costs.
The conversation also dives into:
- The nuances of working with payors & the need for robust data
- The importance of listening to payors needs
- The need for sustained investment
- The evolving landscape of reimbursement policies
—----
Stay connected with our host, Perry Dimas, here on LinkedIn!
25集单集
分享
